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Over the last decades, survival rates have increased tremendously in infants with congenital 
heart disease (CHD). Focus of attention has therefore gradually shifted from preventing 
mortality towards optimizing treatment outcome. It is known that infants with CHD may 
experience short-term and long-term cardiac complications.1 Furthermore, they are at risk 
for neurodevelopmental impairments later in life.2 These impairments can manifest itself 
variably, involving various aspects such as (mild) impairments in cognition, fine and gross 
motor skills, executive functioning, visual construction and perception, attention, social 
interaction and core communication skills.2 While several risk factors have been described 
for adverse neurodevelopmental outcome (NDO), such as for example hypoxic-ischemic 
events, the exact timing of brain injury in infants with CHD is still unknown. The main aim of 
this thesis was, therefore, to gain more insight into the timing of brain injury in infants with 
CHD by assessing hemodynamic characteristics regarding cerebral circulation and brain 
function using non-invasive clinical tools at several moments during the prenatal and early 
postnatal period. Furthermore, we assessed the association between these non-invasive 
clinical tools and short-term NDO. Outcome variables of this thesis are presented in Figure 
1 and main findings of the thesis are summarized in Table 1. 
Figure 1 Outcome variables of the thesis. MRI, magnetic resonance imaging; HC, head circumference; 
NIRS, near-infrared spectroscopy; aEEG, amplitude-integrated electroencephalography; Bayley, Bayley 








Doppler flow profiles (2,3,6,7,9), MRI (2), HC (3,6)  
NIRS (2,4,5,6,7,8,9), aEEG (2,7), MRI (2), HC (6)  
NIRS (8,9)  































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Part I Literature overview
In the first part of this thesis (Chapter	2), we present systematic overview of the literature 
regarding the association between prenatal or postnatal preoperative cerebral findings and 
NDO in infants with CHD. Cerebral findings included prenatal cerebral MRI and Doppler 





electroencephalography (aEEG), cerebral MRI and cranial ultrasound. Abnormal cerebral 
findings were common in infants with CHD both prenatally and postnatally. Furthermore, 
although frequently within the normal ranges, infants with CHD almost always had 
poorer NDO scores in comparison with healthy term infants. The prenatal period as well 
as the postnatal period seemed to play an important role in neurodevelopment in infants 
with CHD. Prenatally, both abnormal Doppler flow patterns and signs of delayed brain 




 and signs of brain 
injury on MRI were associated with adverse NDO. The association between abnormalities on 
preoperative cranial ultrasound or aEEG and NDO was less clear.
Part II Prenatal and postnatal cerebral findings
This part of the thesis focuses on prenatal and postnatal hemodynamic characteristics 
regarding cerebral circulation and brain function in infants with CHD. In several studies, 





 (Chapter	4,	5,	6,	and	8) and aEEG (Chapter	7) in infants with 
various types of CHD. Prenatally, fetuses with CHD often showed abnormal Doppler flow 
patterns, suggestive of preferential brain perfusion (Chapter	3,	6,	and	7). Furthermore, fetuses 
with CHD had smaller HC which only became apparent in the near-term period (Chapter	
3,	and	6). Doppler flow patterns seemed to be associated with head growth and expected 
oxygen delivery to the brain in one study (Chapter	6), while this association could not be 





in comparison with healthy term infants during the first three days after birth or admission to 
the NICU (Chapter	4,	5,	6,	and	8). In infants with left-sided obstructive lesions, we also observed 




) compared with healthy term infants (Chapter	 5)








 decreased gradually while 
other hemodynamic parameters did not indicate that clinical deterioration was imminent 




, we also observed smaller HC one week after birth (Chapter	6),
 abnormal aEEG background patterns, and subclinical epileptic activity (Chapter	7). There 





and we were also unable to demonstrate an association between prenatal Doppler flow 




Part III Neurodevelopmental outcome 
In this part (Chapter	9) we present the first longitudinal prospective study that assessed the 





and short-term NDO in infants with CHD. Short-term NDO was 
defined as the quality of general movements (GMs) at an age of approximately 3 months. 
Our main findings were that prenatal Doppler flow patterns, indicative of preferential brain 
perfusion, were associated with adverse short-term NDO in infants with CHD. Postnatal 




and FTOE, on the other hand, were 
not clearly associated with NDO. The combination of abnormal Doppler flow patterns 




 after birth was associated with a nine-fold increased risk 
for abnormal short-term NDO, suggesting a cumulative effect of hypoxic-ischemic events 
during the prenatal period and early postnatal life. 
Etiology of brain injury
The etiology of brain injury in infants with CHD is multifactorial. In Figure 2 we provide 
a theoretical model of the proposed mechanisms responsible for brain injury in infants 
with CHD. This model is based on findings from this thesis as well as previous literature. We 
speculate that there are two main contributors to brain injury in infants with CHD, namely 
1) a disruption of genetic pathways and 2) hemodynamic alterations. 














Other factors, such as: 
- Impaired autoregulation 
- Anesthetic neurotoxicity 
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The disruption of genetic pathways was not studied in thesis, but previous studies show that 
development of the heart and brain occur simultaneously in the human fetus and that they 
share several genetic pathways such as sonic hedgehog, notch, jagged, NKx2.5, fibroblast 
growth factor beta, and retinoic acid.3-5 A disruption in one of these pathways could affect 
organogenesis of both organs. Recently, several de novo mutations in different genes have 
been identified in infants with non-syndromal CHD.6 Furthermore, Homsy et al identified de 
novo genetic mutations in infants with CHD and neurodevelopmental impairments. A key 
finding was that infants with CHD and neurodevelopmental impairments have mutations 
particularly in genes that are expressed both in heart and brain, suggesting a common 
genetic origin for CHD as well as brain anomalies.7
The second contributor to brain injury in infants with CHD, hemodynamic alterations, has 
been studied in this thesis and will be discussed extensively in the section ‘Timing	of	brain	
injury,	the	prenatal	period’. In summary, CHD can potentially lead to prenatal hemodynamic 
alterations due to intracardiac and extracardiac mixing of oxygenated and deoxygenated 
blood or due to outflow tract obstructions.8-16 These hemodynamic alterations might cause 
(intermittently) impaired cerebral oxygen delivery, inadequate to fulfill the metabolic demand 
of the developing brain, which is highly dependent on adequate oxygen and nutrient supply.5 
Both the disruption of genetic pathways and hemodynamic alterations might lead to 
delayed brain development.3-5,17,18 Fetuses with CHD often have smaller HC (Chapter	3	and	
6), smaller brain volumes, lower total brain weight, increased intra-ventricular and extra-
axial cerebrospinal fluid volumes, a sulcation delay of up to 4 weeks and an altered cerebral 
metabolism.16,19-27 After birth, infants with CHD have smaller HC (Chapter	6) and signs of 
developmental delay of the brain are still present.28-36 These signs include an overall reduction 
in brain volume of up to 21%, a lower white matter fractional anisotropy and NAA/Cho 
ratio, and a higher mean average diffusivity, lac/Cho ratio, Cho/Cr ratio and Mi/Cr ratio.28-36 
Mean total maturation scores are significantly lower in infants with CHD in comparison with 
healthy term infants and correspond to a delay of approximately 4 weeks.36 
This delay in brain maturation might lead to an increased vulnerability of brain tissue 
for hypoxic-ischemic insults during the prenatal and early postnatal period. The young 
developing brain acquires characteristic patterns of injury that reflect the vulnerability of 
specific cell populations and the timing of injury.17 White matter injury (WMI) is one of the 
most commonly observed lesions in infants with CHD.24,31,32,37,38 This type of brain injury is 
usually seen in preterm infants, whereas term infants more often have injury to grey matter 
or neuronal structures.39-40 The proposed mechanism for WMI in preterm infants is a cellular 
maturation arrest of progenitors of oligodendrocytes that predominate in white matter 
during the third trimester.40 Early-lineage oligodendrocytes have less defense mechanisms 
(i.e. anti-oxidant capacity) to insults such as hypoxic-ischemic events in comparison with 




Timing of brain injury
The prenatal period
As stated above (section ‘Etiology of brain injury’), CHD can potentially cause prenatal 
hemodynamic alterations that lead to impaired cerebral oxygen and nutrient supply. 
This hemodynamic instability could be reflected by prenatal Doppler flow patterns. In 
response to acute or chronic hypoxia, fetuses redistribute their cardiac output away from 
the peripheral vascular beds and towards essential circulations such as the brain.41-45 This 
phenomenon is called brain sparing and is characterized by a lower pulsatility index of 
the middle cerebral artery (MCA-PI), a higher pulsatility index of the umbilical artery (UA-
PI), and a lower cerebroplacental ratio (CPR).8-16 In Chapter	2,	3,	6,	7,	and	9 we frequently 
observed prenatal Doppler flow patterns suggestive of brain sparing in fetuses with CHD. 
Previous studies also observed lower MCA-PI, higher UA-PI and lower CPR in fetuses with 
CHD, particularly in fetuses with CHD associated with impaired cerebral oxygen supply. 
We also studied the association between prenatal Doppler flow patterns and expected 
cerebral oxygen delivery according to type of CHD in Chapter	3	and	6. In our prospective 
study (Chapter	6), there seemed to be an association with expected cerebral oxygen delivery, 
with fetuses with low expected cerebral oxygen delivery showing the lowest MCA-PI. In a 
larger retrospective study (Chapter	3), however, this association could not be reproduced. 
This might be due to differences in study methodology. In Chapter	 6 we selected one 
measurement prior to birth and only used descriptive statistics, while in Chapter	3 we used 
a liner mixed-effects model to assess Doppler trends throughout pregnancy. Furthermore, 
different classification methods were used to define low, reduced and normal oxygen 
delivery to the brain. Alternatively, in fetuses with CHD, hypoperfusion might have a more 
profound effect on cerebral oxygen delivery in comparison with hypoxemia. Differences in 
oxygen saturation in the ascending aorta between fetuses with expected normal, reduced 
or low oxygen delivery to the brain are relatively small (65% vs. 60%) and might be too 
subtle to cause differences in Doppler flow patterns. The effect of hypoperfusion has to be 
further investigated. One study found lower MCA-PI in fetuses with left-sided obstructive 
lesions with retrograde blood flow in the ascending aorta in comparison with fetuses with 
left-sided obstructive lesions with antegrade blood flow in the ascending aorta, suggesting 
that brain vessel dilatation may especially occur in the first type of lesions.12
Regarding the association between prenatal Doppler flow patterns and NDO, there are 
two main theories. Brain sparing might either be a protective mechanism or it might be 
an insufficient mechanism to compensate for brain underperfusion. Two studies found a 
negative association between Doppler flow patterns and psychomotor developmental 
index (Bayley II) suggesting that brain sparing is an adaptive and protective mechanism 
to compensate for either decreased cerebral oxygen supply or decreased cerebral blood 
flow.9,46 Another small study, on the other hand, found a positive association between 
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Doppler flow patterns and cognitive outcome (Bayley III) suggesting that brain sparing 
is an insufficient mechanism to compensate for brain underperfusion.15 One other study 
could not confirm either one of the theories.14 This thesis supports the theory that brain 
sparing in fetuses with CHD is an insufficient compensatory mechanism and a sign of brain 
vulnerability, as brain sparing was associated with adverse short-term NDO (Chapter	9). 
Contradictory results concerning the association between prenatal Doppler flow 
patterns and NDO outcome in infants with CHD might be due to differences in study 
design and study methodology. First, NDO was assessed using different validated tests 
(GMs, Bayley II, and Bayley III) at different ages (3 months to 18 months of age). In Chapter	9, 
we used the quality of GMs at an age of 3 months according to Prechtl’s method to assess 
short-term NDO. General movements are spontaneous movements that involve the entire 
body and are present from fetal life until approximately 5 months of age.47,48 Particularly 
GMs at an age of 3 months (fidgety period) are an accurate marker to assess the integrity 
of the young nervous system with a high sensitivity and specificity for neurodevelopment 
at an older age.49-52 Second, most studies used a single Doppler measurement at various 
moments during pregnancy (first measurement after diagnosis or last measurement 
before birth), while there is increasing evidence that hemodynamic responses change over 
time and particularly late assessments are more representative (Chapter	3).8 Furthermore, 
Doppler flow patterns vary with fetal behavior, fetal heart rate and fetal breathing and 
recent studies are lacking on the effects of these variables on variability and reproducibility 
in fetuses with CHD.53,54 Third, various types of CHD were included, which may have different 
pathophysiological and circulatory effects. Brain sparing might be a protective mechanism 
in some types of CHD, while it is a sign of fetal distress in others. 
Postnatal period
After birth, hypoxic-ischemic events form an additional threat to the young developing 
brain of the infant with CHD. We frequently observed mildly abnormal aEEG background 





 values prior to, during, and 24 hours after surgery (Chapter	4-6,	8,	and	9). 
Their exact contributions to NDO, however, remain unclear.
Previous studies in infants with CHD often reported abnormal aEEG background patterns, 
(sub)clinical seizures, and absence of sleep-wake cycling (SWC) prior to surgery.55-58 While 
these abnormalities have been associated with brain injury on preoperative MRI,56 a clear 
association between preoperative aEEG abnormalities and NDO could not be demonstrated. 
We also observed mildly abnormal background patterns and subclinical seizures, but almost 
all neonates developed SWC during the first 3 days after birth (Chapter	7). Furthermore, we 
observed less frequent and less severe aEEG abnormalities in comparison with previous 




CHD, suggesting that immediate treatment after birth may prevent hypoxic-ischemic events 
and therefore has a beneficial effect on brain function in these infants. In Chapter	7, we also 
reported a strong association between abnormal preoperative aEEG background patterns 
and use of sedatives during the first 3 days after birth. Sedatives have been known to cause 
a transient depression of electro-cortical activity in several different study populations.59-62 
Some authors therefore state that interpreting aEEG recordings in infants who are treated 
with sedatives is unreliable and should be avoided.59,61 Based on these findings, we speculate 
that there are two explanations for the non-existent association between preoperative 
aEEG and NDO. First, preoperative aEEG abnormalities are relatively mild in infants with CHD, 
particularly in prenatally diagnosed cases and are therefore not related to NDO later in life. 
Alternatively, abnormal aEEG background patterns prior to surgery might be a transient 
effect of treatment with sedatives instead of a sign of brain injury. 
For this thesis, we did not study intraoperative and postoperative aEEG, nor did we 
assess the association between aEEG abnormalities during this period and NDO. Previous 
studies reported isoelectric or low voltage activity during deep hypothermic circulatory 
arrest during surgery. Furthermore, intraoperative seizures were frequently reported in 
infants with CHD. A significant association was reported between intraoperative seizures 
and mortality, but not with NDO.57,58 Postoperative aEEG abnormalities, on the other hand, 
did seem to be associated with adverse cognitive and motor outcome in infants with CHD. 
Both abnormal background patterns, delayed recovery of background patterns and lack of 
return to SWC within 48 hours after surgery were strongly related to poorer NDO at 2 and 
4 years of age.57,58,63 Postoperatively, aEEG background abnormalities were more severe in 
comparison with aEEG abnormalities prior to surgery. This might explain why postoperative 
aEEG abnormalities are associated with NDO while preoperative abnormalities are not. 




 values prior to surgery, during surgery and following 




 values, both before, during and after cardiac surgery, were 
frequently below previously established hypoxic-ischemic thresholds in piglets.71,72 Prior to 




 values, however, 
this difference did not reach statistical significance. There are various explanations for this 










 and NDO in infants with different types of CHD. Second, hypoxia 
or ischemia duration might have been too short to cause permanent brain injury. Kurth et 
al. demonstrated that an episode of hypoxia/ischemia of ≥ 2 hours was required to cause 
permanent brain injury in neonatal piglets.71 In our study, near-infrared spectrometers were 




 values. Third, we 
speculate that neonates with CHD are able to recover from hypoxic-ischemic events during 
early life. Brain development continues throughout childhood and involves not only the 
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onset of new pathways and connections, but also elimination of others.73 Due to the high 
plasticity of the young brain, previous abnormalities might disappear, at least transiently. 





 and NDO in infants with CHD. We were unable to demonstrate an 
association (Chapter	9). Previous studies, on the other hand, reported varying correlations. 
Cerebral oxygen saturation during and after surgery alone, however, was never a strong 
predictor of NDO.64,65,68,74 It can be argued that surgical techniques and postoperative 
intensive care have improved in such a way that additional brain injury is prevented. 
Alternatively, it might be that there is not a single predictor for NDO in infants with CHD, 
but that NDO is dependent on a combination of prenatal and postnatal factors.
Cumulative effect – Knudson hypothesis
In 1971, Alfred G. Knudson proposed the theory that two mutational events are necessary 
to cause cancer.75 Since then, the two-hit hypothesis has been put forward in a number 
of diseases where onset of disease cannot clearly be linked to a specific genetic or 
environmental insult, such as autism or schizophrenia.76,77 
The two-hit hypothesis might also be true for NDO in infants with CHD. While we 





 (Chapter	6) or aEEG (Chapter	7), we did observe a nine-fold increased risk of 
having abnormal short-term NDO in infants with CHD with two or more hypoxic-ischemic 
events during the prenatal and early postnatal period (Chapter	 9). The combination of 
an increased vulnerability of the cerebrum due to a disruption of genetic pathways or 
circulatory alterations (first hit) and subsequent hypoxic-ischemic events (second hit) might 
affect NDO in infants with CHD. 
Future perspectives
This thesis provides insight into the timing of brain injury in infants with prenatally diagnosed 
CHD. Particularly the prenatal period seems to be an important contributor to NDO in infants 
with CHD. Furthermore, there might be a cumulative effect of hypoxic-ischemic events 
during the prenatal period and early postnatal life. However, many uncertainties regarding 
brain injury in infants with CHD still exist. The exact role of the early postnatal period remains 
unclear. Furthermore, the association between hemodynamic characteristics regarding 
cerebral circulation and brain function and NDO might differ according to the type of CHD. 
Finally, it is important to assess whether the association between prenatal Doppler flow 
patterns and NDO is confirmed by larger studies. Future large multicenter studies, including 
prospectively followed cohorts of fetuses with different types of CHD followed according 
a strict protocol and with an adequate duration of follow-up (at least until childhood, but 




type of CHD. Only after this has been achieved a definitive conclusion on the presence and 
significance of cerebral hemodynamic changes, on the onset of brain injury and hopefully 
on possible preventive strategies can be reached.
A clear finding of this thesis is that adverse NDO is common in infants with CHD. When 
comparing NDO of infants with CHD with other at risk populations, such as infants with 
hypoxic-ischemic encephalopathy (HIE) or preterm born infants, results are quite similar 
(Table 2).78 In the Netherlands, infants with HIE and preterm born infants are part of a 
national follow-up program. We believe that infants with CHD should also be incorporated 
into a follow-up program to allow for early identification and early interventions. In fact, 
there is some evidence that NDO improves after early intervention in preterm infants.79 
Apart from risk stratification according to type of CHD and early identification and 
intervention of potential problems, future studies should focus on preventative strategies. 
Pharmacological neuroprotection and fetal cardiac intervention might be promising for 
infants with CHD. A number of medications have been proposed for neuroprotection.80 
First, allopurinol is a xanthine oxidase inhibitor that has both neuroprotective as well as 
cardiovascular protective effects. It can be administered both prenatally and postnatally 
as it crosses the placenta. In experimental studies neuroprotective effects have been 
demonstrated during both periods.81-83 In neonates with HIE, there is some evidence 
that allopurinol has beneficial effects on NDO.84 In infants with CHD, however, effects of 
allopurinol on NDO have yet to be determined.85 Second, another promising medication 
is topiramate, which may have the potential to prevent WMI by protecting progenitors of 
oligodendrocytes.86 An important mechanism in the development of brain injury in infants 
with CHD might be a maturation arrest of progenitors of oligodendrocytes. Third, caffeine 
has potential neuroprotective effects by inhibiting adenosine.87 Adenosine is released 
during hypoxic-ischemic events and is involved in WMI.88 In preterm infants, caffeine 
administration has been associated with improved NDO.89 Randomized-controlled trials 
will be needed to evaluate the full potential of pharmacological neuroprotection in the 
fetus and neonate with CHD. Finally, the benefits and risks of fetal cardiac interventions 
should be further explored. Theoretically, some types of CHD might be considered for fetal 
cardiac intervention in this respect (severe aortic stenosis evolving to hypoplastic left heart 
syndrome (HLHS), pulmonary atresia with hypoplasia of the right ventricle, and HLHS with 
restrictive atrial septum).90 Although the procedure nowadays is often technically successful, 
beneficial effects for cardiac and NDO have yet to be determined.90,91
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Table 2 Overview of the prevalence of major outcome categories in the largest at-risk populations.
HIE Very preterm CHD
Prevalence 1-6/1000 10/1000 6/1000
Cerebral palsy 30%, TH: 20% 5-10% 2%
IQ < 70 30% 10-20% 10-20%
Mild deficits ~50% ~50% ~30-50%
HIE, hypoxic-ischemic encephalopathy; CHD, congenital heart disease; TH, therapeutic hypothermia. Adapted from: 
Latal B. Neurodevelopmental Outcomes of the Child with Congenital Heart Disease. Clin Perinatol 2016;43:173-185.
Conclusion
In conclusion, infants with congenital heart disease often have poorer neurodevelopmental 
outcomes in comparison with healthy term infants. Hemodynamic characteristics of 
cerebral perfusion and brain function during the prenatal and early postnatal life seem to 
be associated with neurodevelopmental outcome. Particularly the prenatal period seems 
to play an important role in neurodevelopmental outcome in infants with congenital heart 
disease. Postnatally, however, abnormal cerebral oxygen saturation and brain function were 
also frequently observed. Their exact contribution to neurodevelopmental outcome has yet 
to be determined. Based on the results of this thesis, we suggest the concept that, in infants 
with congenital heart disease, the first hit contributing to abnormal neurodevelopment 
occurs during the fetal period. Developmental delay may be the result of abnormal genetic 
pathways combined with hemodynamic alterations leading to an increased vulnerability 
for hypoxic-ischemic events of the young developing brain. Postnatal events may represent 
the second hit. This thesis further demonstrates that non-invasive clinical investigations can 
be helpful in identifying fetuses at risk for adverse neurodevelopment. However, longitudinal 
studies with an adequate duration of follow-up and risk stratification according to type of 
congenital heart disease are necessary, as brain development is not impaired in all types of 
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